RT Journal Article
T1 Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
A1 Salvador, Javier
A1 Aparicio, Jorge
A1 Baron, Francisco Javier
A1 Garcia-Campelo, Rosario
A1 Garcia-Carbonero, Rocio
A1 Lianes, Pilar
A1 Llombart, Antonio
A1 Isla, Dolores
A1 Piera, Josep Manuel
A1 Munoz, Montserrat
A1 Puente, Javier
A1 Rivera, Fernando
A1 Rodriguez, Cesar A
A1 Virizuela, Juan Antonio
A1 Martin, Miguel
A1 Garrido, Pilar
K1 Antineoplastic agents
K1 Barriers
K1 Heterogeneity
K1 Inequities
K1 Spain
AB The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels. An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals. 77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs. The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.
YR 2016
FD 2016-08-25
LK http://hdl.handle.net/10668/10391
UL http://hdl.handle.net/10668/10391
LA en
DS RISalud
RD Apr 6, 2025